SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMCM.L Regulatory News (MCM)

  • There is currently no data for MCM

Appendix 5B

30 Jul 2021 08:01

RNS Number : 0550H
MC Mining Limited
30 July 2021
Β 

Appendix 5B

Mining exploration entity or oil and gas exploration entityquarterly cash flow report

Name of entity

MC Mining Limited

ABN

Β 

Quarter ended ("current quarter")

98 008 905 388

30 June 2021

Β 

Consolidated statement of cash flows

Current quarter$USD'000

Year to date (twelve months)$USD'000

1.

Cash flows from operating activities

7,140

22,831

1.1

Receipts from customers

1.2

Payments for

(a) exploration & evaluation

(b) development

(c) production

(5,890)

(19,707)

(d) staff costs

(463)

(2,026)

(e) administration and corporate costs

(648)

(3,050)

1.3

Dividends received (see noteΒ 3)

1.4

Interest received

-

-

1.5

Interest and other costs of finance paid

(18)

(121)

1.6

Income taxes paid

1.7

Government grants and tax incentives

1.8

Other (provide details if material)

-

1

1.9

Net cash from / (used in) operating activities

121

(2,072)

2.

Cash flows from investing activities

2.1

Payments to acquire or for:

(a) entities

(b) tenements

(c) property, plant and equipment

(100)

(244)

(d) exploration & evaluation

(6)

(45)

(e) investments

0

(447)

(f) other non-current assets

2.2

Proceeds from the disposal of:

(a) entities

(b) tenements

(c) property, plant and equipment

-

510

(d) investments

514

514

(e) other non-current assets

2.3

Cash flows from loans to other entities

2.4

Dividends received (see noteΒ 3)

2.5

Other (provide details if material)

(110)

2.6

Net cash from / (used in) investing activities

408

178

3.

Cash flows from financing activities

-

885

3.1

Proceeds from issues of equity securities (excluding convertible debt securities)

3.2

Proceeds from issue of convertible debt securities

3.3

Proceeds from exercise of options

3.4

Transaction costs related to issues of equity securities or convertible debt securities

3.5

Proceeds from borrowings

1,225

5,597

3.6

Repayment of borrowings

(325)

(1,668)

3.7

Transaction costs related to loans and borrowings

3.8

Dividends paid

3.9

Other (provide details if material)

(277)

98

3.10

Net cash from / (used in) financing activities

623

4,912

4.

Net increase / (decrease) in cash and cash equivalents for the period

4.1

Cash and cash equivalents at beginning of period

2,316

464

4.2

Net cash from / (used in) operating activities (itemΒ 1.9 above)

121

(2,072)

4.3

Net cash from / (used in) investing activities (itemΒ 2.6 above)

408

178

4.4

Net cash from / (used in) financing activities (itemΒ 3.10 above)

623

4,912

4.5

Effect of movement in exchange rates on cash held

(237)

(251)

4.6

Cash and cash equivalents at end of period

3,231

3,231

Β 

Β 

5.

Reconciliation of cash and cash equivalentsat the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts

Current quarter$USD'000

Previous quarter$USD'000

5.1

Bank balances

5,292

3,135

5.2

Call deposits

38

37

5.3

Bank overdrafts

(2,099)

(856)

5.4

Other (provide details)

5.5

Cash and cash equivalents at end of quarter (should equal itemΒ 4.6 above)

3,231

2,316

Β 

6.

Payments to related parties of the entity and their associates

Current quarter$USD'000

6.1

Aggregate amount of payments to related parties and their associates included in itemΒ 1

34

6.2

Aggregate amount of payments to related parties and their associates included in itemΒ 2

Note: if any amounts are shown in items 6.1 or 6.2, your quarterly activity report must include a description of, and an explanation for, such payments.

7.

Financing facilitiesNote: the term "facility' includes all forms of financing arrangements available to the entity.

Add notes as necessary for an understanding of the sources of finance available to the entity.

Total facility amount at quarter end$USD'000

Amount drawn at quarter end$USD'000

Β 

7.1

Loan facilities

11,312

11,312

Β 

7.2

Credit standby arrangements

-

-

Β 

7.3

Other (please specify)

2,687

Β 

2,687

Β 

7.4

Total financing facilities

13,999

13,999

Β 

Β 

7.5

Unused financing facilities available at quarter end

-

Β 

7.6

Include in the box below a description of each facility above, including the lender, interest rate, maturity date and whether it is secured or unsecured. If any additional financing facilities have been entered into or are proposed to be entered into after quarter end, include a note providing details of those facilities as well.

Β 

Β 

All facilities are denominated and are repayable in South African Rand (ZAR)

Β 

7.1 Loan Facilities $USD11.3 million:Lender: Industrial Development Corporation of South Africa ("IDC").

Maturity date: 31 January 2022. In the case of an un-remedied default, the debt is convertible into shares

Interest rate: accrues at a real after -tax rate of return of 16% on the amount advanced.

Security: Unsecured

Β 

7.3 Other $USD2.7 million:

Lender: ABSA Group Limited

a) $USD 1.4 million overdraft facility

b) $USD 0.7 million short term loan

c) $USD 0.6 million finance leases

Β 

Maturity Date

a) Reviewed annually

b) 1 December 2021 (6 monthly instalments commenced 30 June 2021)

c) Various dates

Β 

Interest Rate:

a) Floating rate: South African Prime plus 1%

b) Floating rate: South African Prime plus 1%

c) Floating rate: South African Prime less 0.5%

Β 

Security

a) Receivables

b) Receivables

c) Underlying leased assets

Β 

Β 

Β 

8.

Estimated cash available for future operating activities

$USD'000

8.1

Net cash from / (used in) operating activities (itemΒ 1.9)

121

8.2

(Payments for exploration & evaluation classified as investing activities) (item 2.1(d))

(6)

8.3

Total relevant outgoings (itemΒ 8.1 + itemΒ 8.2)

115

8.4

Cash and cash equivalents at quarter end (itemΒ 4.6)

3,231

8.5

Unused finance facilities available at quarter end (itemΒ 7.5)

-

8.6

Total available funding (itemΒ 8.4 + itemΒ 8.5)

3,231

8.7

Estimated quarters of funding available (itemΒ 8.6 divided by itemΒ 8.3)

N/A

Note: if the entity has reported positive relevant outgoings (ie a net cash inflow) in itemΒ 8.3, answer itemΒ 8.7 as "N/A". Otherwise, a figure for the estimated quarters of funding available must be included in item 8.7.

8.8

If itemΒ 8.7 is less than 2Β quarters, please provide answers to the following questions:

8.8.1 Does the entity expect that it will continue to have the current level of net operating cash flows for the time being and, if not, why not?

Answer:

Β 

8.8.2 Has the entity taken any steps, or does it propose to take any steps, to raise further cash to fund its operations and, if so, what are those steps and how likely does it believe that they will be successful?

Answer:

Β 

8.8.3 Does the entity expect to be able to continue its operations and to meet its business objectives and, if so, on what basis?

Answer:

Β 

Note: where itemΒ 8.7 is less than 2Β quarters, all of questions 8.8.1, 8.8.2 and 8.8.3 above must be answered.

Β 

Compliance statement

1 This statement has been prepared in accordance with accounting standards and policies which comply with Listing RuleΒ 19.11A.

2 This statement gives a true and fair view of the matters disclosed.

Β 

Β 

Date: ...................................................................................

Β 

Authorised by: .......... Disclosure Committee.........................................................................

(Name of body or officer authorising release - see noteΒ 4)

Β 

Β 

Notes

1. This quarterly cash flow report and the accompanying activity report provide a basis for informing the market about the entity's activities for the past quarter, how they have been financed and the effect this has had on its cash position. An entity that wishes to disclose additional information over and above the minimum required under the Listing Rules is encouraged to do so.

2. If this quarterly cash flow report has been prepared in accordance with Australian Accounting Standards, the definitions in, and provisions of, AASB 6: Exploration for and Evaluation of Mineral Resources and AASB 107: Statement of Cash Flows apply to this report. If this quarterly cash flow report has been prepared in accordance with other accounting standards agreed by ASX pursuant to Listing RuleΒ 19.11A, the corresponding equivalent standards apply to this report.

3. Dividends received may be classified either as cash flows from operating activities or cash flows from investing activities, depending on the accounting policy of the entity.

4. If this report has been authorised for release to the market by your board of directors, you can insert here: "By the board". If it has been authorised for release to the market by a committee of your board of directors, you can insert here: "By the [name of board committee - eg Audit and Risk Committee]". If it has been authorised for release to the market by a disclosure committee, you can insert here: "By the Disclosure Committee".

5. If this report has been authorised for release to the market by your board of directors and you wish to hold yourself out as complying with recommendationΒ 4.2 of the ASX Corporate Governance Council's Corporate Governance Principles and Recommendations, the board should have received a declaration from its CEO and CFO that, in their opinion, the financial records of the entity have been properly maintained, that this report complies with the appropriate accounting standards and gives a true and fair view of the cash flows of the entity and that their opinion has been formed on the basis of a sound system of risk management and internal control which is operating effectively.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCWPUMAMUPGUQU
Date   Source Headline
21st Dec 20159:30 amRNSPublication Of Offer Document
17th Dec 20157:00 amRNSCOMPETITION COMMISSION APPROVAL
9th Dec 201512:02 pmRNSEnvironmental Authorisation Interdict Update
7th Dec 20157:00 amRNSUpdate on Offer Funding
1st Dec 20153:14 pmRNSMOU for Makhado Project
1st Dec 201511:00 amRNSDirector/PDMR Shareholding
30th Nov 20158:15 amRNSResult of AGM
30th Nov 20157:00 amRNSASIC Relief
26th Nov 20157:09 amRNSRecommended Offer for Universal Coal PLC
19th Nov 20157:00 amRNSUpdate to Environmental Authorisation at Vele
30th Oct 20157:01 amRNSAppendix 5B
30th Oct 20157:00 amRNSQuarterly Report ended 30 September 2015
26th Oct 201510:00 amRNSDespatch of Annual Report and Notice of AGM
16th Oct 201511:22 amRNSISSUE OF SHARES AND SECONDARY TRADING NOTICE
16th Oct 201511:21 amRNSAppendix 3B
7th Oct 20158:45 amRNSHoldings in Company
1st Oct 20157:00 amRNSHoldings in Company
30th Sep 20157:00 amRNSHoldings in Company
25th Sep 20157:00 amRNSHolding(s) in Company
22nd Sep 201512:00 pmRNSHolding(s) in Company
21st Sep 20157:00 amRNSCompletion of Yishun equity and loan transactions
15th Sep 20157:00 amRNSResults of General Meeting
10th Sep 201512:00 pmRNSFull Year Results for the Period Ending June 2015
10th Sep 201512:00 pmRNSAudited Annual Consolidated Financial Statements
14th Aug 201512:00 pmRNSDespatch of Notice of General Meeting
5th Aug 20157:00 amRNS£9.4 million equity investment & $10 million loan
27th Jul 20157:01 amRNSAppendix 5B
27th Jul 20157:00 amRNSQuarterly Report ended 30 June 2015
2nd Jul 20157:00 amRNSMooiplaats update
23rd Jun 20159:52 amRNSAppendix 3X
22nd Jun 20157:00 amRNSDirectorate Change
15th Jun 20157:00 amRNSChange of Adviser
5th Jun 20151:30 pmRNSHoldings in Company
3rd Jun 201512:00 pmRNSAppendix 3B
3rd Jun 201512:00 pmRNSNOTICE ISSUED SECTION 708A CORPORATIONS ACT 2001
2nd Jun 20153:35 pmRNSSuccessful completion of Equity Raise
1st Jun 20157:00 amRNSCapital Raising Update
18th May 20157:00 amRNSMining Right granted for the Makhado Project
12th May 20157:00 amRNSSoutpansberg amendment agreement signed
5th May 20157:01 amRNSMooiplaats Disposal Update
30th Apr 20157:00 amRNSCapital Raising Update
23rd Apr 20157:00 amRNSDirector Notification
23rd Apr 20157:00 amRNSAppendix 5B
23rd Apr 20157:00 amRNSQuarterly Report ended 31 March 2015
19th Mar 20157:00 amRNSDirector Share Purchase
17th Mar 20154:40 pmRNSSecond Price Monitoring Extn
17th Mar 20154:35 pmRNSPrice Monitoring Extension
13th Mar 20157:01 amRNSInterim Financial Report
13th Mar 20157:00 amRNSInterim Financial Commentary
13th Mar 20157:00 amRNSMakhado Project Empowerment Structuring Completed

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.